BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33357600)

  • 1. Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA).
    Rouzier C; Chaussenot A; Paquis-Flucklinger V
    Arch Pediatr; 2020 Dec; 27(7S):7S9-7S14. PubMed ID: 33357600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy patient detection and carrier screening using dried blood spots on filter paper.
    Harahap NI; Harahap IS; Kaszynski RH; Nurputra DK; Hartomo TB; Pham HT; Yamamoto T; Morikawa S; Nishimura N; Rusdi I; Widiastuti R; Nishio H
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):123-9. PubMed ID: 21942573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling.
    Dobrowolski SF; Pham HT; Downes FP; Prior TW; Naylor EW; Swoboda KJ
    Clin Chem; 2012 Jun; 58(6):1033-9. PubMed ID: 22490618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative Project.
    Prior TW; Bayrak-Toydemir P; Lynnes TC; Mao R; Metcalf JD; Muralidharan K; Iwata-Otsubo A; Pham HT; Pratt VM; Qureshi S; Requesens D; Shen J; Vetrini F; Kalman L
    J Mol Diagn; 2021 Jan; 23(1):103-110. PubMed ID: 33197628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III.
    Zheleznyakova GY; Kiselev AV; Vakharlovsky VG; Rask-Andersen M; Chavan R; Egorova AA; Schiöth HB; Baranov VS
    BMC Med Genet; 2011 Jul; 12():96. PubMed ID: 21762474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world evidence: Risdiplam in a patient with spinal muscular atrophy type I with a novel splicing mutation and one SMN2 copy.
    Ma K; Zhang K; Chen D; Wang C; Abdalla M; Zhang H; Tian R; Liu Y; Song L; Zhang X; Liu F; Liu G; Wang D
    Hum Mol Genet; 2024 Jun; 33(13):1120-1130. PubMed ID: 38520738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA).
    Lefebvre S; Sarret C
    Arch Pediatr; 2020 Dec; 27(7S):7S3-7S8. PubMed ID: 33357595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular analysis of survival motor neuron gene in 338 suspicious children patients with spinal muscular atrophy].
    Song F; Qu YJ; Zou LP; Wang LW; Long MJ; Wang X; Yang YL; Chen Q; Wang H; Jin YW
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):919-23. PubMed ID: 19134255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMA Diagnosis: Detection of SMN1 Deletion with Real-Time mCOP-PCR System Using Fresh Blood DNA.
    Niba ETE; Ar Rochmah M; Harahap NIF; Awano H; Morioka I; Iijima K; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2017 Dec; 63(3):E80-E83. PubMed ID: 29434179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.
    Carré A; Empey C
    J Genet Couns; 2016 Feb; 25(1):32-43. PubMed ID: 26250347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].
    Gong B; Zhang L; Hou YP; Hu HY; Li HC; Tan MY; Chen J; Yu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):670-2. PubMed ID: 24327144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patients.
    Bora-Tatar G; Yesbek-Kaymaz A; Bekircan-Kurt CE; Erdem-Özdamar S; Erdem-Yurter H
    Eur J Med Genet; 2015 Dec; 58(12):654-8. PubMed ID: 26548498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.